Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomic Study to Predict Toxicity and Response in Colorectal Cancer Patients Treated With Oxaliplatin-based Chemotherapy

NCT00977717 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT00977717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00977717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomic Study to Predict Toxicity and Response in Colorectal Cancer Patients Treated With Oxaliplatin-based Chemotherapy
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
April 30, 2010
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

curatively resected stage iii colon cancer